The Response to Intralesional IL-2 and/or BCG Treatment for Cutaneous Metastatic Melanoma
Clinical trial NCT03928275 · WITHDRAWN
Trial details
- NCT number
- NCT03928275
- Sponsor
- Carman Giacomantonio
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.